OINDPnews


Proveris Scientific

News

Strados Labs gets CE mark for RESP lung sounds sensor

Strados Labs announced that its RESP Smart Sensor Platform, which remotely measures and records lung sounds for use in respiratory disease treatment and clinical trials, has been granted a CE mark. According to Strados, a number of clinical trial sponsors are using measurements made by the RESP system as endpoints in studies of drugs in development for the treatment … [Read more...] about Strados Labs gets CE mark for RESP lung sounds sensor

Brigham and Women’s Hospital announces Phase 1 trial of intranasal vaccine for Alzheimer’s

Brigham and Women’s Hospital (BWH) has announced an upcoming clinical trial of an intranasal vaccine for the prevention and treatment of Alzheimer’s disease (AD). The SAD trial is expected to enroll 16 early-staged Alzheimer's patients aged 60-85 who will each get two doses of the vaccine, with the second dose administered one week following the first dose. The … [Read more...] about Brigham and Women’s Hospital announces Phase 1 trial of intranasal vaccine for Alzheimer’s

Akari Therapeutics chooses Inhalation Sciences for PK study of inhaled Nomacopan

According to Inhalation Sciences (ISAB), Akari Therapeutics has chosen ISAB's CRO, Inhalation Research Services, to conduct a pharmacokinetic study of Akari's Nomacopan, a C5 and LTB4 inhibitor that the company is evaluating as an inhaled therapy for the treatment of exacerbations in COPD and asthma. The PK study will be conducted using an isolated perfused lung (IPL) … [Read more...] about Akari Therapeutics chooses Inhalation Sciences for PK study of inhaled Nomacopan

DDL 2021 to offer a mix of live and on-demand content

For the second year, the Drug Delivery to the Lungs conference will take place virtually as a result of the COVID-19 pandemic. The conference will include both live and recorded scientific presentations, live discussion sessions, and a digital exhibition happening online December 8-10. The meeting will open at 10:00 a.m. UK time on each of the three days, and the live … [Read more...] about DDL 2021 to offer a mix of live and on-demand content

Phase 1 trial of Pneumagen’s Neumifil nasal spray gets underway

Pneumagen has announced the initiation of a Phase 1 SAD/MAD study of its Neumifil carbohydrate binding module (mCBM) nasal spray, which the company is developing for the prevention and treatment of viral respiratory infections. The company said that it expects topline results to be available in the first half of 2022. At the beginning of 2021, Pneumagen announced … [Read more...] about Phase 1 trial of Pneumagen’s Neumifil nasal spray gets underway

Birmingham Biotech licenses antiviral nasal spray from the University of Birmingham

Birmingham Biotech said that it has licensed a carrageenan/gellan antiviral nasal spray from the University of Birmingham and intends to market the spray in the UK and in Asian countries for protection against COVID-19 starting in early 2022. The license excludes marketing rights in India but includes the rest of the world. Birmingham Biotech currently sells … [Read more...] about Birmingham Biotech licenses antiviral nasal spray from the University of Birmingham

Pulmatrix and Cipla resolve dispute over Pulmazole funding

According to Pulmatrix, a dispute between Pulmatrix and Cipla over funding related to the development of Pulmazole intraconazole DPI (PUR 1900) has been resolved. In May 2021, Pulmatrix announced that Cipla had failed to provide 50% of the development costs for Pulmazole and had therefore breached the terms of their development and commercialization agreement for the … [Read more...] about Pulmatrix and Cipla resolve dispute over Pulmazole funding